MycoBiomDB – Record Details (MyCo_3360)

Biomarker Record Details

Database ID: MyCo_3360
DB IDMyCo_3360
TitleSingle-cell immune checkpoint landscape of PBMCs stimulated with Candida albicans
Year2021
PMID34120578
Fungal Diseases involvedCandida albicans infection
Associated Medical ConditionNone
GenusCandida
Speciesalbicans
OrganismCandida albicans
Ethical StatementThis study was approved by the Clinical Research Ethics Committee of the Peking University First Hos- pital. We obtained blood samples from healthy donors and candidemia patients after obtaining informed consent.
Site of InfectionNone
Opportunistic invasiveNone
Sample typeBody fluid
Sample sourceBlood
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameLY6E
Biomarker Full NameLY6E
Biomarker TypeDiagnostic
BiomoleculeGene
Geographical LocationChina
CohortNone
Cohort No.None
Age GroupNone
P ValueNone
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismC. albicans accounts for the most frequently isolated pathogen of candidemia, which causes approxi- mately 40% mortality despite antifungal treatment. Moreover, candidemia is a major challenge for healthcare as difficult diagnosis and therapy. For- tunately, as technical development, single-cell RNA- sequencing (scRNA-seq) has been widely used to gen- erate new scientific insights in various fields. Thus, efforts to analyze genomic transcripts of PBMCs stimulated with C. albicans based on single-cell levels will build a foundation for developing novel thera- peutic targets and potential genes with the most rel- evant for C. albicans infection to improve the clinical outcomes of candidemia.
TechniqueAnalytic
Analysis MethodFlow Cytometry Analysis
ELISA kitsNone
Assay DataNone
Validation Techniques usedFlow Cytometry Analysis, RNAseq analysis
Up Regulation Down RegulationPositive
Sequence DataNone
External LinkNone